Trade Idea: GILD

I am BEARISH on $Gilead Sciences(GILD)$ at its current levels.

Here's a look at its daily chart:

The stock failed to break above 90, which was the same spot where it failed back in January 2018 - back then, it made a high of 89.54 before pulling back over 25 points. This suggests that 90 is an extremely strong historical resistance level for the stock. The stock hit the upper Bollinger Band a few days ago on the attempt to break 90, which signified the start of a short opportunity from there. Currently, it has broken the middle Bollinger Band which suggests that a strong downside move is coming in the coming days. I am inclined to lean bearish on the contracting Bollinger Bands, with increased volume on yesterday's red candle. I have plotted the fibonacci retracement levels on the chart above. Minimally, I'm looking for a downside move to 83s. Ultimately, I'm targeting the gap fill back to 70s from back in October.

That being said, the stock has been holding support at the 20DMA and the 21EMA since September. Breaking both of these likely signal the start of a pullback. I have gotten some puts expiring in February 2023, in anticipation of the gap filling by then. While there were rumblings of a merger with $AstraZeneca PLC(AZN)$ back in June 2020, those rumblings have not materialised and I expect such rumours to be insignifcant in the longer term. 

So, how do you trade this stock? You can get 85P expiring in early January (i.e. 4-5 weeks out). If you're worried about any upside move, then you can hedge with 87C that has the same expiry (smaller size as compared to puts). In other words, a strangle strategy. If the broader market bounces, it's possible that the stock might get a lift from here, however, the chart sure does look like it's going to roll over in the short term similar to $Amgen(AMGN)$ . Good luck everyone!

If you enjoyed this post, then leave a like and/or a comment on my post and follow me for more of such posts!

@TigerWire @TigerStars $SPDR S&P 500 ETF Trust(SPY)$ $Spdr S&P Biotech Etf(XBI)$ 

voteLong(Single choice)
20 people voted· Ended

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment69

  • Top
  • Latest
  • nimbly
    ·2022-12-16
    TOP
    It seems that GILD is hitting a wall around $89.
    Reply
    Report
    Fold Replies
    • TBITrades
      historical resistance at 90 not broken since 2018 so it either needs a strong positive catalyst or it needs to ride market strength
      2022-12-16
      Reply
      Report
  • didiling
    ·2022-12-16
    TOP
    thanks for sharing
    Reply
    Report
    Fold Replies
    • TBITrades
      np. if you like my posts leave me a follow for more of such informative posts... always glad to share
      2022-12-16
      Reply
      Report
  • JuliusGoldsmith
    ·2022-12-16
    TOP
    Are there any chances to break the historical resistance level? looks hard if simply wacthing at the volume
    Reply
    Report
    Fold Replies
    • JuliusGoldsmithReplying toTBITrades
      Yep, even investors confidence are little. It can't be
      2022-12-16
      Reply
      Report
    • TBITrades
      needs a catalyst for sure. I doubt it's that easy to break a level that hasn't been tested since 2018
      2022-12-16
      Reply
      Report
  • bubblyx
    ·2022-12-16
    TOP
    If you notice, Gilead was probably one of the only profitable Pharma that didn't make a new All time high this year.
    Reply
    Report
    Fold Replies
    • TBITrades
      doesn't need to make a new ATH. amgen peaked recently and has been dropping and Gilead will follow suit
      2022-12-16
      Reply
      Report
  • cheerzy
    ·2022-12-16
    To me GILD is a recession-proof stock, like ADM, NTR.
    Reply
    Report
    Fold Replies
    • TBITradesReplying toTBITrades
      there are notable exceptions to this but a lot of them just act as shields
      2022-12-16
      Reply
      Report
    • TBITrades
      recession proof stocks don't necessarily go up in recession they just protect investors from heavier downside.
      2022-12-16
      Reply
      Report
  • Trevelyan
    ·2022-12-16
    So high it can touch the sky.. as well as the thunder which can point it down...
    Reply
    Report
  • Aqa
    ·2022-12-18
    May i check how di you make the ‘Neutral/Short vote’ game at the bottom of your post? Thanks v
    Reply
    Report
  • bullditt
    ·2022-12-16
    Great ariticle, would you like to share it?
    Reply
    Report
    Fold Replies
    • stkwok
      Like
      2023-01-01
      Reply
      Report
  • DaveLewis
    ·2022-12-16
    Looks like an inverted U-shaped trend.
    Reply
    Report
  • Gloria112
    ·2022-12-16
    gonna roll over. strangle strategy is 👍good
    Reply
    Report
  • TBITrades
    ·2022-12-16
    woops sorry guys. I messed up the poll. [Happy]
    Reply
    Report
  • x2espresso
    ·2022-12-16
    I m bearish too.
    Reply
    Report
  • Irene lee
    ·2022-12-19
    Ok
    Reply
    Report
  • kktan
    ·2022-12-19
    ok
    Reply
    Report
  • Newnew
    ·2022-12-19
    Hi
    Reply
    Report
  • Unknown934
    ·2022-12-19
    Eow
    Reply
    Report
  • Siti Saniah
    ·2022-12-19
    ok
    Reply
    Report
  • 211013能量飞车
    ·2022-12-18
    👍
    Reply
    Report
  • Jean0031
    ·2022-12-18
    Like
    Reply
    Report
  • Alisont09
    ·2022-12-18
    Nice
    Reply
    Report